The induction of eosinophil peroxidase release: improved methods of measurement and stimulation
- PMID: 15345309
- DOI: 10.1016/j.jim.2004.05.003
The induction of eosinophil peroxidase release: improved methods of measurement and stimulation
Abstract
The production and release of eosinophil peroxidase (EPO) has been associated with human pathology. Degranulation assays with eosinophils are typically very difficult to do, with very low release values. EPO is unique for its high cationic charge. As such, it adheres to most extracellular surfaces, rendering it more difficult to measure compared with other released cellular proteins. Based on the understanding of the sticky nature of EPO, we were concerned that EPO released in vitro cannot be reproducibly measured in the supernatants of stimulated cells. Instead, we suspected that much of the released EPO was left adherent to the tube walls. We chose to investigate the measurement of EPO activity using the peroxidase substrate, O-phenylenediamine (OPD). Unlike other peroxidase substrates, OPD is soluble in aqueous physiological solutions, which do not lyse cell membranes, thereby allowing us to add OPD directly to eosinophils and exclusively measure extracellular EPO. This novel approach would remove the concerns of incorrect EPO measurements due to its adhesive nature. In addition, we developed this method to quantify EPO release in terms of EPO concentration. Finally, using this technique, we have been able to demonstrate secretory IgA (s-IgA)-induced release of EPO. By using OPD, we have developed a more sensitive and specific method to analyze the release of extracellular EPO.
Similar articles
-
[The measurement of superoxide generation and eosinophil peroxidase (EPO) from eosinophils].Nihon Rinsho. 1993 Mar;51(3):730-5. Nihon Rinsho. 1993. PMID: 8388065 Review. Japanese.
-
Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation.Eur J Immunol. 1995 Jan;25(1):117-25. doi: 10.1002/eji.1830250121. Eur J Immunol. 1995. PMID: 7843220
-
Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.Arch Biochem Biophys. 1994 Jul;312(1):67-74. doi: 10.1006/abbi.1994.1281. Arch Biochem Biophys. 1994. PMID: 8031148
-
Eosinophilic granuloma of the bone in Hand-Schüller-Christian disease: extensive in vivo eosinophil degranulation and subsequent binding of released eosinophil peroxidase (EPO) to other inflammatory cells.J Pathol. 1991 Mar;163(3):225-31. doi: 10.1002/path.1711630307. J Pathol. 1991. PMID: 1707451
-
[EPO release from eosinophils].Nihon Rinsho. 1997 Mar;55 Suppl 1:219-21. Nihon Rinsho. 1997. PMID: 9097593 Review. Japanese. No abstract available.
Cited by
-
PI3-kinase regulates eosinophil and neutrophil degranulation in patients with allergic rhinitis and allergic asthma irrespective of allergen challenge model.Inflammation. 2012 Feb;35(1):230-9. doi: 10.1007/s10753-011-9309-5. Inflammation. 2012. PMID: 21384093
-
Human eosinophil adhesion and degranulation stimulated with eotaxin and RANTES in vitro: lack of interaction with nitric oxide.BMC Pulm Med. 2008 Aug 12;8:13. doi: 10.1186/1471-2466-8-13. BMC Pulm Med. 2008. PMID: 18700028 Free PMC article.
-
Lung immunoreactivity and airway inflammation: their assessment after scorpion envenomation.Inflammation. 2012 Apr;35(2):501-8. doi: 10.1007/s10753-011-9338-0. Inflammation. 2012. PMID: 21547500
-
Biodegradation of single-walled carbon nanotubes by eosinophil peroxidase.Small. 2013 Aug 26;9(16):2721-9, 2720. doi: 10.1002/smll.201202508. Epub 2013 Feb 27. Small. 2013. PMID: 23447468 Free PMC article.
-
Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs.J Immunol Methods. 2018 Mar;454:76-79. doi: 10.1016/j.jim.2017.11.005. Epub 2017 Nov 14. J Immunol Methods. 2018. PMID: 29154772 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous